Hummingbird Diagnostics is developing innovative, minimally-invasive molecular tests for early disease detection, precision medicine, and lifetime health monitoring based on miRNA biomarkers from blood. While concentrating on the development of own proprietary miRNA blood tests, Hummingbird is offering its expertise and ISO-certified processes to 3rd parties who are interested in building diagnostics/companion diagnostics and therapeutics based on miRNAs from blood.
Focusing on the leading cause of cancer death worldwide, it’s lead project is a diagnostic test for the early detection of lung cancer from whole blood. The specific targeted blood test seeks to improve the lung cancer detection process providing a simple method to identify lung cancer at an early stage. Currently the test is under clinical validation with leading cancer care providing hospitals in the US.
Besides cancer, the company is focusing on the development of biomarkers for neurodegenerative diseases and wellness.
Hummingbird Diagnostics GmbH
Im Neuenheimer Feld 583
Phone: +49 6221 9143310
Get in contact with German companies in 3 easy steps! With one single question you can reach all relevant German Pavilion exhibitors of your selected industrial branch.
Click here if you notice an image that violates copyright or privacy rights.